Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole for Central Serous Chorioretinopathy
NCT00211393Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- May 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketoconazole in Central Serous Chorioretinopathy (CSCR), sponsored by Manhattan Eye, Ear and Throat Hospital. Started May 2005; status: completed.
02
Drugs
ketoconazole
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT00211393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211393.